Reddit Posts
MDAI - “We are pleased to reach this milestone towards the initial commercialization opportunity for our DeepView AI®-Burn algorithm."
MDAI - announced the submission of an application in the United Kingdom for its predictive software DeepView AI®-Burn to be registered as UK Conformity Assessed (UKCA) for burn wound use in the UK.
MDAI - The DeepView® Wound Imaging System
MDAI nice day to accumulate with FDA pending news
MDAI nice day to accumulate with FDA pending news FDA
MDAI nice opportunity to load up today
MDAI nice week ahead...enjoy the ride
MDAI in the last post I forgot to post CTB situation
MDAI has only 240k float with 50% SI and CTB around 300%
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%.
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%..
NEGG lot of spamming posts by shorters...hope you took your profits. If you are looking for a nice squeeze MDAI is one of the best. The new hype is here.
Did you load up some MDAI in the last days...?
MDAI where could go with the squeeze and the news incoming?
MDAI very tiny float..high SI.. CTB around 300% and news incoming
MDAI accumulation is ending..nice squeeze incoming
Hope you loaded up enough MDAI 2 days ago... squeeze incoming
MDAI very tiny float ..high SI and CTB around 300%
MDAI could pop hard today with tiny float
Penny stocks to watch now? 4 turning heads this week
$MDAI micro float with +$100M in contracts
Mentions
Well I'm stuck with $2.5 MDAI so MDAI it is... :/
MDAI as long as it get approved by the FDA, which seems likely.
What I'm watching this week - DFLI, ASST and MDAI earnings tomorrow.
Essentially a ticket which guarantees you a stock at a certain price. If you have warrants at $2, but MDAI shares are now $10. You can exercise your warrants and buy stock at $2. They do also have an expiry date so slightly riskier than buying stock
MDAI continuing to base well ahead of FDA approval and potential strategic acquisition after that
Does MDAI have a potential FDA approval date?
MDAI - just got thru raising growth capital. Clear path to fda approval and already funded by the Defense Dept. TROX - just look at the all time chart. Nice yield, cyclical low, rare earth upside.
MDAI Spectral AI looks good. Coming month can be big with the FDA approval
Thanks! I like it. Check out MDAI. They have fda approval coming up for their device. It is an easy sell to hospitals , govt. Etc. And this is where AI is very useful right now. It will save hospitals money.
I think the problem is deeper than that and using Reddit as your sole intuition on stocks will make you lag most of the time. Bynd was a nice grab here recently but overall I’m learning that Reddit mostly fails to deliver (CCCX, USAR, MDAI) and instead I’m leaning back into my own intuition. For example I think water is becoming scarce. So I’m investing in water purification companies. Or I believe in climate change, so I’m buying ac and heating stocks, lastly I want companies that are profiting year after year.
All these pump/dump is risky business! $MDAI looks solid mid-long term. Still not a bad entry point. Government contracts, FDA approval most likely and you can potentially double your money in just a few months.
MDAI holding up nicely despite the growth capital raise. Now full steam ahead to fda approval and commercialization
TMC, ADUR, BEEM, MDAI, and REKR. I’m also starting to scale into a position in SNCR. These are all in my small speculative portfolio, most of my money is either in a pension or passive funds. If you’ve got any questions about my picks, I’d be happy to answer them!
Keeping a close eye on DFLI, MDAI, NUAI the next few days
I never went to this sub before, but randomly went in too check, saw the DD on BYND and I thought it was solid enough and meme-y enough. Of course you can always buy more and there are things to regret but I managed to buy at 0.6 and some calls at 0.8. The next thing I'm looking at is $MDAI, but I mainly don't know what I'm doing.
Not for MDAI - grinding higher day by day
Never enter a stock thats already gone, its like try to enter a moving car. And dont have the mentality of ”nerd to make my money back” that will make you desperate enough to enter a new bad trade and trigger à downfall spiral. Thats doesnt mean that there isnt good stocks being recommended here and that you shouldn’t try to make your losses back but try to be smart about it. Check my latest post about MDAI, this is the kind of trades i make, i lower the risk by chosing strong stocks fundamentally that actually have legs to stand on snd then pick the right window to buy and hold. Read the post and you will get and idea of how i do it. That said, it doesnt make it bulletproof but atleast lowers the risk to a level where it makes it more rewarding than stressful. Good Luck 🫡
$MDAI showing a lot of strength today, feels like new positions are getting added and a floor is forming around $2.50. Warrants showed unusually high volume (6x average) and a 30% intraday spike. We may see upper $3 later this week/next week. This stock blows up a 50% run on a positive FDA update if I had to guess.
Great overview! I’ve been believing in this value play since mid-2024 and my portfolio is 2/3rds just this micro cap. The fundamental technology has been nothing but good news, filling a diagnostic niche for burns but also will expand to diabetic foot ulcers and I’m sure a range of other wound types. FDA approval will confirm the viability of this technology for burn and likely other indications and will make MDAI a juicy buyout target, especially with $95 million of BARDA funding getting unlocked upon approval.
Im buying MDAI Monday it’s on discount
MDAI a better bet but hope these vegan burger mofos get their bread lol
MDAI is a pump dump stock. It’s had 2 major pumps in the past 5yrs but is has also had a MASSIVE decline since its original stock price. That stock is bears and bulls playing games with each other. Sure- potential for a 2x but not reliable and you can never predict which way it’s going to go since it relies on temporary hype
I posted about SLS forever ago. (Not a penny) but also archer at $9. Posted about HIT at $0.80. Posted about MDAI still moving up. Just actually read the dd and do your own. There are still people posting about real growth potential companies. Someone posted about NUAI @ $0.48 I biught $1000 and sold because I got weak hands but just got to did through the trash and you’ll find the gold. Posted about PFSA before they had a 150% move the day before and got downvoted into oblivion. PBM and CGEN are still sleeper companies.
MDAI - SpectralAI makes DeepView which is an AI-powered scanning device that uses spectral data scans to predict burn healing to a high accuracy and creates the optimal treatment plan day 1. Trials were a huge success and now they are waiting on FDA approval by Q1 26. It is also trained on diabetic foot ulcers which is an even larger market. FDA approval odds are 80-90%, in my opinion. They are fully funded by BARDA (US gov), so there is minimal dilution risk. I see this company reaching several 100M market cap in 1 year, up to 1B in a strong scenario, and 5-10B longterm. ACON - Super tiny 4-5M market cap with 100x potential. Aclarion is run by Jeff Thramann who is a highly regarded surgeon-inventor / neurosurgeon. He has taken several companies/products to commercialization in the medical industry. Aclarion makes Nociscan which is an AI system that integrates into MRIs. For pain caused by spinal disc issues, it is often not possible to tell which (or all) of the discs are causing pain, and that results in more fused vertebrae than necessary. However, Nociscan is able to detect pain markers and directly identify the disc that's causing the pain. Previous trials were a big success and current trial is ongoing with results expected mid-2026. The trials showed higher success rate of pain reduction/surgery success vs not using Nociscan, while also being cheaper, which makes it a perfect case for adoption. Insurance companies will likely require its use. This is highly speculative obviously, but I see this possibly hitting 50M market cap (10x) in 2-3 years with potential for much more longterm if it is widely adopted. The TINY float is only 532k shares which means it will move fast on any positive headlines.
How about ORGN for under a 1$? Also i think MDAI has real potential for some room to grow with the AI boom priced around 2.60$
Brief synopsis for each. I hold them all. MDAI - 70M - SpectralAI makes DeepView which is an AI-powered scanning device that uses spectral data scans to predict burn healing to a high accuracy and creates the optimal treatment plan day 1. Trials were a huge success and now they are waiting on FDA approval by Q1 26. It is also trained on diabetic foot ulcers which is an even larger market. FDA approval odds are 80-90%, in my opinion. They are fully funded by BARDA (US gov), so there is minimal dilution risk. I see this company reaching several 100M market cap in 1 year, up to 1B in a strong scenario, and 5-10B longterm. ACON - 5M - Super tiny market cap with 100x potential. Aclarion is run by Jeff Thramann who is a highly regarded surgeon-inventor / neurosurgeon. He has taken several companies/products to commercialization in the medical industry. Aclarion makes Nociscan which is an AI system that integrates into MRIs. For pain caused by spinal disc issues, it is often not possible to tell which (or all) of the discs are causing pain, and that results in more fused vertebrae than necessary. However, Nociscan is able to detect pain markers and directly identify the disc that's causing the pain. Previous trials were a big success and current trial is ongoing with results expected mid-2026. The trials showed higher success rate of pain reduction/surgery success vs not using Nociscan, while also being cheaper, which makes it a perfect case for approval. Insurance companies will likely require its use. This is highly speculative obviously, but I see this possibly hitting 50M market cap (10x) in 2-3 years with potential for much more longterm if it is widely adopted. The TINY float is only 532k shares which means it will move fast on any positive headlines. RDZN - 100M - Roadzen is an insurtech company that makes DriveBuddyAI which helps commercial fleets and insurers detect and predict risky driver behavior, provide drowsiness alerts, score driver risk, and improve fleet safety and efficiency. Other companies have similar tech, however RDZN is uniquely positioned in India because they are the only AIS-184 certified device in the country. India also has a new law coming up next year that says all commercial vehicles must have an AIS-184 certified device installed, and RDZN is the only one with that certification. They also just got certified in EU a few days ago and just today announced a partnership with a top 5 EU carmaker. Their other revenue streams are also growing but the big catalyst for me is the India market next year which could instantly unlock 100M of revenue. I see this at $500M in a couple years, possibly sooner if their growth accelerates. The CEO recently reiterated they will turn profitable by Dec 2025 and they just raised a ton of non-dilutive cash (at a premium even), so there is very small dilution risk. AMPX - 2B - Mass drone warfare is the future, and Amprius happens to make the best drone battery on the market, competitors to SiCore are still pre-product/pre-revenue. They are in Amazon's Devices Climate Tech Program and advanced to phase 2. They will likely announce a partnership with Amazon for proprietary drone batteries. Well, this part is just my speculation, but there is no other reason for Amazon to be interested in them. They also crush every earnings. Likely 20B company in a few years. And yes of course, their batteries can do more than drones.
ALRT and MDAI for me. Both massive TAM, strong growth, evolving and unaddressed sectors, good connections with government bodies. If you want a short term potential gainer, ABVE is set to reverse merge with Palm Global, a tokenisation firm hoping to manage $1.5 Trillion worth of RWA, "launching with $350B in U.S. gold-based assets", and boarded by members of the Dubai royal family. To be honest I don't know what that values the company at, but I'm guessing it's more than the current ≈$200M ABVE is valued at.
Which app do you use to buy MDAI?
MDAI screams BUY to me. Fully funded, minimal dilution risk, likely FDA approval. One of my strongest conviction plays. Here are some basic details: SpectralAI makes DeepView which is an AI-powered scanning device that uses spectral data scans to predict burn healing to a high accuracy and creates the optimal treatment plan day 1. Trials were a huge success and now they are waiting on FDA approval by Q1 26. It is also trained on diabetic foot ulcers which is an even larger market. FDA approval odds are 80-90%, in my opinion. They are fully funded by BARDA (US gov), so there is minimal dilution risk. I see this company reaching several 100M market cap in 1 year, up to 1B in a strong scenario, and 5-10B longterm.
MDAI is doing great! The point of this question is strange, especially since you mentioned Atos. There are many other specialists. I don't like to listen to analysts, but MDAI is between $3.50 and $6. Bad valuations look different! I think it's just not moving fast enough for you. You're impatient, but I'm not a psychologist. Before you buy shares, take a close look at when the right time to enter is. Analysts at BTIG and Northland Capital Markets have reiterated their positive ratings for Spectral AI. BTIG reiterated a buy rating with a price target of $3.00 in March 2025, based on revenue of $7.6 million in the fourth quarter of 2024 and projected revenue of $21.5 million for 2025. Northland Capital Markets set a price target of $6.00 in March 2025 after the company presented promising results from a study on the DeepView® system. 🧠 Technological Innovation Spectral AI has developed its DeepView® system, a non-invasive AI-based solution that offers high accuracy in burn assessment. In a clinical study, DeepView achieved 95.3% accuracy in determining surgical burn depth, while surgeons on average only achieved 40.8%. This represents a significant advance in medical diagnostics. Reddit 💼 Financial Performance In the first quarter of 2025, Spectral AI reported net income of $2.9 million, a gross margin of 47.2%, and a 6% increase in research and development revenue to $6.7 million. The company strengthened its capital base with a $14.1 million financing, which supports its upcoming product commercialization efforts. TipRanks 🏛️ Strategic Partnerships Spectral AI received a $500,000 contract from the U.S. Defense Health Agency to develop a wearable version of the DeepView® system. This contract confirms the importance of the company's technology, particularly for solutions in battlefield burn care. Wall Street Journal 🔍 Conclusion Experts and analysts are optimistic about Spectral AI's technological innovations and financial progress. The positive reviews and strategic partnerships indicate the company's promising potential. I wish you the best of luck, stay tuned...
I’ve been accumulating since August 2024, I believe it to be way undervalued at <$100m cap, even now as my position has only increased in share count and warrant exposure. Analysts since 2024 have been giving price targets from $6-10. My personal bullish price targets are $5 upon approval and float to $10 by end of 2026. $25 for a mature burn indication revenue stream priced in. This could be priced in as soon as a year passes of burn commercialization (2027); business segment maturation in 5-7 years. My 2032 target is $400 after MDAI becomes a multi-indication global healthcare diagnostic supplier (they are already targeting US, UK, Europe, and Australia) with at least the burn and diabetic foot ulcer indications commercialized.
I’m not going to go into a full spiel on this comment, but if you’re interested, check out my previous posts on this stock. It’s my main holding in my portfolio despite its micro cap status because its story seems bulletproof. Spectral AI ($MDAI) is a pre-revenue company waiting on FDA approval of its DeepView AI burn imaging system by early 2026. They already have the studies done showcasing significant machine learning model wound healing prediction accuracy over surgeons. And their multi spectral imaging and analysis technology is scalable to healing wounds in general, their next target is the huge tens of billions market of diabetic foot ulcers. What makes this pre-revenue company different from other promising stories is that they’ve been working with the US government since 2013 on their research and development and have achieved $250 million of contractual funding, $95 million of which is unlocked to support commercialization after FDA approval. Additionally, the US government is going to acquire at least 200 of these systems automatically and begin a nice base of consistent annuity fee high-margin revenue for the company.
Spectral Ai ($MDAI) and Hyperfine ($HYPR) are two medical device companies I have high expectations for. Both of them are sub $3.00 at the moment.
These are my top plays. AMPX - 1.6B - Mass drone warfare is the future, and Amprius happens to make the best drone battery on the market, competitors to SiCore are still pre-product/pre-revenue. They are in Amazon's Devices Climate Tech Program and advanced to phase 2. They will likely announce a partnership with Amazon for proprietary drone batteries. Well, this part is just my speculation, but there is no other reason for Amazon to be interested in them. They also crush every earnings. Likely 20B company in a few years. And yes of course, their batteries can do more than drones. MDAI - 67M - SpectralAI makes DeepView which is an AI-powered scanning device that uses spectral data scans to predict burn healing to a high accuracy and creates the optimal treatment plan day 1. Trials were a huge success and now they are waiting on FDA approval by Q1 26. It is also trained on diabetic foot ulcers which is an even larger market. FDA approval odds are 90%, in my opinion. They are fully funded by BARDA (US gov), so there is minimal dilution risk. I see this company reaching several 100M market cap in 1 year, up to 1B in a strong scenario, and 5-10B longterm. ACON - 5M - Super tiny market cap with 100x potential. Aclarion is run by Jeff Thramann who is a highly regarded surgeon-inventor / neurosurgeon. He has taken several companies/products to commercialization in the medical industry. Aclarion makes Nociscan which is an AI system that integrates into MRIs. For pain caused by spinal disc issues, it is often not possible to tell which (or all) of the discs are causing pain, and that results in more fused vertebrae than necessary. However, Nociscan is able to detect pain markers and directly identify the disc that's causing the pain. Previous trials were a big success and current trial is ongoing. The trials showed higher success rate of pain reduction vs not using Nociscan, while also being cheaper, which makes it a perfect case for approval. This is highly speculative obviously, but I see this hitting 50M market cap (10x) in 2-3 years with potential for much more longterm if it is widely adopted. The TINY float is only 532k shares which means it will move FAST on any positive headlines. RDZN - 100M - Roadzen is an insurtech company that makes DriveBuddyAI which helps commercial fleets and insurers detect and predict risky driver behavior, provide drowsiness alerts, score driver risk, and improve fleet safety and efficiency. Other companies have similar tech, however RDZN is uniquely positioned in India because they are the only AIS-184 certified device in the country. India also has a new law coming up next year that says all commercial vehicles must have an AIS-184 certified device installed, and RDZN is the only one with that certification. They also just got certified in EU a few days ago and just today announced a partnership with a top 5 EU carmaker. Their other revenue streams are also growing but the big catalyst for me is the India market next year which could instantly unlock 100-200M of recurring revenue. I see this at $500M in a couple years, possibly sooner if their growth accelerates. The CEO recently reiterated they will turn profitable by Dec 2025 and they just raised a ton of non-dilutive cash (at a premium even), so there is very small dilution risk.
Loving the solid momentum on MDAI - take a look folks :)
What do you think of MDAI
MDAI interesting AH action yesterday
Thank you! I’m only in MDAI and COCH that need FDA approval for anything.
MDAI a solid legitimate opportunity
MDAI . and PDYN - that betch wanna squeeeze ! 🍋 
MDAI 🤌🏻 
So you think a stock rising this much before FDA approval won’t rise much more? Or it won’t rise enough to be worth the upside? The FDA approval is going to be a major catalyst as you have seen in here time and time again. There will be a big boom and bust. So use that event to pay off the shares you want to keep because it will most likely fall right back down. I still think it will be higher than whatever you enter at today, but no promises. But just DCA into it if you are worried. You don’t have to do large lump sums and you definitely can swing trade shares to get a better cost average over time. A recent biotech that got FDA approval is MBOT, so you can look at them as a potential reference point for the pre-FDA approval run up, the approval, the drop, the climb back up. But for more specific help and insights on MDAI, go to the MDAI Reddits. One of them uses the name Spectral AI in the name. The great news is, the US military wants this product ASAP. That is your main commercialization driver and funder. Hopefully it will lead to a less dilutive commercialization effort. They won’t have to fight tooth and nail for those first sales. They’re pretty much in the bag. The product is also highly touted by those who’ve used it for trials overseas, which is why confidence is high that Spectral AI’s tech will be approved. It’s not invasive or dangerous. The reliability of the AI is the main concern on this one. It also already made it into Time Magazine for one of the best techs in healthcare. You’re never going to find a unicorn of a stock that can avoid dilution. Execs want to be paid in stock. Mergers or acquisitions will have dilution. Getting into the Russell index will sometimes require some dilution to have more shares available to trade. Commercialization is expensive. Scaling up is expensive. Building a few MDAI units is peanuts to building thousands of them and providing software help. It’s all just a part is the journey, and this is where you pay a lot more attention to if they are being good stewards with the extra capital and doing their best to get financing on good terms instead of on toxic debt terms. The MDAI Reddit’s have timelines, videos, etc. MDAI is already working it overseas while waiting on FDA approval here. They aren’t just sitting on their hands or anything. They are already getting the word out. Spectral is a great company. Just a very quiet company. But they do make the most of every opportunity in the conferences they go to it seems like. Share prices seem to always go up after one. The main issue as a shareholder is how much money you want to have tied up while waiting on FDA approval and commercialization. I used to have 750 - 1000 shares depending on the month. I trimmed down to 100. When it’s closer to FDA approval is when I’ll load up. I just don’t want a ton of cash tied up dead for months and months. I won’t have the best cost basis, but I’ll make that money up on all the trading done on other stocks between now and then. MDAI is going go be a long term hold no matter what, just like MBOT.
Not for today but for the next year - MDAI
MDAI - govt funded med device utilizing ai to treat wounds. Already has traction in Europe and likely buyout target
Legend has it that this is the group that helps those in need by pumping their heavy baggings. The following are my bags. Please pump: IINN, MDAI, XAIR, LFMD. Thank you in advance.
Any penny stocks out there that aren't pump and dumps? Long term hold, good growth potential. What are your thoughts on MDAI?
MDAI de-SPACed in Sept. 2023.
Pretty sure his take is to the moon, why else would he be all in otherwise? I haven't seen MDAI much just saw the chart, why was there a 80% fall in September 2023?
Im basically all in on MDAI so i like the sound of this
GRAL will keep pumping, then maybe MDAI
MDAI https://preview.redd.it/fajxwo2i6atf1.jpeg?width=1320&format=pjpg&auto=webp&s=69775ad166f5c7b77c871730d9e3605314228071
Maybe MDAI, maybe not. Could be 6 mos.
$MDAI is undervalued and a hidden gem. Stoked to see you all get into it with me and make some $$$
MDAI - Skow and steady for sustained moves higher
I’ve got 3k shares in MDAI. It’s an amazing concept and they’re getting good results. I think it’ll be a longer hold though as it’s mode ling takes time and there’s a lot of process to go through
OPEN and RIGETTI blowing up setting the stage for MDAI QD and INNODATA to set the tone for the market big home run with COPX to compliment the demand as an increase in utility. Next move on to production stocks and manufacturers with the mindset on material costs and expenses like gas oil (i.e energy) for sure wish I bought more INNO. With a spike today going to 82! Calling out MDAI 👀. Let’s goo !! QD 🍑god like platform structure..don’t sleep on that pharma market 🤫 😴 💊 Follow for more mentions on the market
MDAI is the heavy sleeper buying 500 more to get the most gain next week
I will be topping up LUNR, MDAI & UPST shortly!
$MDAI going unnoticed by the masses
MDAI continues to solidify - primed for a takeout target
Whoa baby GRAL cranking today. MATV basing. Let's see what happens with MDAI.
MDAI - not next week but certainly over next few months with fda approval and greater visibility
Interesting video from MDAI CEO and founder https://youtu.be/cGktsfcfYSM
MDAI. Maybe not for today but definitely over next 3-6 months. Hard to predict when it really starts ramping, could be any day
MDAI continuing to build a good chart with good fundamentals
MDAI easy double up (minimum) in 6 months at approval.
Solid lineup here. I actually dug deeper into these names over the weekend, and the risk/reward looks very favorable short-term. NXXT especially stands out — the Florida land + 200MW grid deal isn’t just hype, that’s real infrastructure value, and the CEO insider buy is a textbook signal. NVNI’s recent acquisitions + earnings momentum could easily fuel the $7–12 target chatter. Even ASST looks like a sleeper with those institutional stakes quietly positioning. MDAI is slower, but the FDA angle with such a tiny market cap vs TAM is exactly the kind of asymmetry that pays big if it hits. HOLO’s the only wild card, but if sentiment turns risk-on, squeezes there can be brutal. Overall I see multiple near-term catalysts — wouldn’t be surprised if 2–3 of these names outperform hard in the next leg up.
Nice to see MDAI move up slow and steady as fda approval looms. $65m market cap with a product slated to address a 15b market opportunity. And history of insider buying.
I’m in MDAI from like a week ago
I have recently bought LUNR, MDAI and UPST for my new ‘[Less than $10k to $1 million](https://www.reddit.com/r/DoubleBubbler/comments/1lvkwxs/less_than_10k_to_1_million_current_value_since/)’ challenge.
Spectral AI (MDAI) Waiting on FDA approval and named in the TIME’s list of top HealthTech companies 2025
MDAI anyone? I’ve been in for like a week or two. I got in at 1.9, at 2.4 now
https://preview.redd.it/b9z5xng5z4qf1.jpeg?width=743&format=pjpg&auto=webp&s=41f28123ef472e89b4e90fd2f17d6564611e5a5c MDAI
Imma put y'all on: $MDAI So much potential!
MDAI , USAS , PDYN 🤌🏻 
https://preview.redd.it/eh13t66huqpf1.jpeg?width=1280&format=pjpg&auto=webp&s=1e5621778d77bbe23356bfc366f397b655cc0fed MDAI 🤌🏻
Im literally done. Placed in voo and voog. Only risky stock i have is MDAI which i know will pay off in a couple years. But the anxiety i get in options is not worth it. Was up 60% (4.2k) on ETHA last friday only to close it today at +5% fml
What do we think about MDAI ?
SKYX , USAS , RR , MDAI 